<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Bone and soft tissue sarcomas, tumors of the skin</journal-id><journal-title-group><journal-title xml:lang="en">Bone and soft tissue sarcomas, tumors of the skin</journal-title><trans-title-group xml:lang="ru"><trans-title>Саркомы костей, мягких тканей и опухоли кожи</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2219-4614</issn><issn publication-format="electronic">2782-3687</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">39</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>BONE SARCOMAS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>САРКОМЫ КОСТЕЙ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">The role of novel prognostic factors in treatment of patient witn spine metastases</article-title><trans-title-group xml:lang="ru"><trans-title>Факторы прогноза при метастатическом поражении позвоночника (Литературный обзор)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kulaga</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Кулага</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>roncspine@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Musaev</surname><given-names>E. R.</given-names></name><name xml:lang="ru"><surname>Мусаев</surname><given-names>Э. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Valiev</surname><given-names>A. K.</given-names></name><name xml:lang="ru"><surname>Валиев</surname><given-names>А. К.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Borzov</surname><given-names>K. A.</given-names></name><name xml:lang="ru"><surname>Борзов</surname><given-names>К. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kabardaev</surname><given-names>R. M.</given-names></name><name xml:lang="ru"><surname>Кабардаев</surname><given-names>Р. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Aliev</surname><given-names>M. D.</given-names></name><name xml:lang="ru"><surname>Алиев</surname><given-names>М. Д.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">FSBI «N.N. Blokhin National Medical Research Center of Oncology» оf the Health Ministry of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-08-16" publication-format="electronic"><day>16</day><month>08</month><year>2018</year></pub-date><volume>10</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>23</fpage><lpage>30</lpage><history><date date-type="received" iso-8601-date="2021-04-16"><day>16</day><month>04</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Kulaga A.V., Musaev E.R., Valiev A.K., Borzov K.A., Kabardaev R.M., Aliev M.D.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Кулага А.В., Мусаев Э.Р., Валиев А.К., Борзов К.А., Кабардаев Р.М., Алиев М.Д.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Kulaga A.V., Musaev E.R., Valiev A.K., Borzov K.A., Kabardaev R.M., Aliev M.D.</copyright-holder><copyright-holder xml:lang="ru">Кулага А.В., Мусаев Э.Р., Валиев А.К., Борзов К.А., Кабардаев Р.М., Алиев М.Д.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://sarbon.abvpress.ru/jour/article/view/39">https://sarbon.abvpress.ru/jour/article/view/39</self-uri><abstract xml:lang="en"><p>It performed the analysis of literature data on assessing cancer prognosis possibilities in patients with spine metastases. Surgical intervention for metastatic spinal lesions is palliative, but the majority of patients who undergo local treatment of a given volume in combination with systemic therapy, have improved their quality of life. It is noted that the adequate determination and use of prognostic factors in clinical practice in the planning of surgical treatment helps to determine spinal surgery volume and assess the life expectancy in this patients. It described the developed prognosis systems (Tokuhashi, Sioutos, Tomita, Van der Linden, Bauer), and it is indicated that these scales differ depending on the parameters included in them and do not take into account the options for systemic treatment of a malignant disease and the presence of mutations in the tumor. It was concluded that the treatment of spinal metastases should be individualized and multidisciplinary, the rational choice of treatment and its scope should be based on a comprehensive assessment of anamnestic, clinical and prognostic data. Accurate assessment of the postoperative survival prognosis will improve the quality of medical care for this category of patients and achieve optimal indicators of quality of life.</p></abstract><trans-abstract xml:lang="ru"><p>Выполнен анализ литературных данных о возможностях оценки онкологического прогноза у больных с метастатическим поражением позвоночника. Хирургические вмешательства при метастатическом поражении позвоночника носят паллиативный характер, однако у большинства пациентов, прошедших локальное лечение того или иного объема в сочетании с системной терапией, отмечается улучшение качества жизни. Отмечено, что адекватное определение и использование прогностических факторов в клинической практике при планировании хирургического лечения помогает определить адекватный объем операции на позвоночнике и оценить предполагаемую продолжительность жизни у рассматриваемой категории пациентов. Рассмотрены разработанные к настоящему времени системы прогноза (Tokuhashi, Sioutos, Tomita, Van der Linden, Bauer), при этом указано, что эти шкалы различаются в зависимости от включенных в них параметров и не учитывают варианты системного лечения злокачественного заболевания и особенности опухолей, а именно наличия мутаций. Сделано заключение о том, что лечение метастатического поражения позвоночника должно быть индивидуализированным и мультидисциплинарным, рациональный выбор метода лечения и его объем должны основываться на комплексной оценке анамнестических, клинических и прогностических данных. Точная оценка прогноза послеоперационной выживаемости позволит улучшить качество медицинской помощи данной категории пациентов и достичь оптимальных показателей качества жизни.</p></trans-abstract><kwd-group xml:lang="en"><kwd>spinal metastases</kwd><kwd>prognostic factors</kwd><kwd>survival score</kwd><kwd>surgical treatment of spinal metastases</kwd><kwd>Tokuhashi scale</kwd><kwd>Tomita scale</kwd><kwd>Bauer scale</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>метастазы в позвоночник</kwd><kwd>факторы прогноза</kwd><kwd>выживаемость</kwd><kwd>шкала Tokuhashi</kwd><kwd>шкала Tomita</kwd><kwd>шкала Bauer</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Kong P, Yan J, Liu D, Ji Y, Wang Y, Zhuang J, Wang J, Hu X, Yue X. Skeletal-related events and overall survival of patients with bone metastasis from nonsmall cell lung cancer - A retrospective analysis. Medicine (Baltimore). 2017;96(51):e9327. DOI: 10.1097/MD.0000000000009327.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Spratt DE, Beeler WH, de Moraes FY, Rhines LD, Gemmete JJ, Chaudhary N et al. An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report. Lancet Oncol. 2017;18(12):e720-e30. DOI: 10.1016/S1470-2045(17)30612-5.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Nater A, Sahgal A, Fehlings M. Management - spinal metastases. Handb Clin Neurol. 2018;149:239-255. DOI: 10.1016/ B978-0-12-811161-1.00016-5.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Zhang JJ, Zhou Y, Hu HY, Sun YJ, Wang YG, Gu YF et al. Safety and efficacy of multilevel vertebroplasty for painful osteolytic spinal metastases: a single-centre experience. Eur Radiol. 2016;27(8):3436-3442. DOI: 10.1007/s00330-016-4683-x.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Алиев МД, Степанова АМ, Мусаев ЭР, Валиев АК, Гуторов СЛ. Метастатическое поражение позвоночника у больных раком молочной железы. Факторы прогноза. Сибирский онкологический журнал. 2015;3:61-67.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Мусаев ЭР, Степанова АМ, Гуторов СЛ, Бурляев ЕВ, Алиев МД. Шкала оценки прогноза при метастазах рака молочной железы в позвоночник. Саркомы костей, мягких тканей и опухоли кожи. 2016;2:27-31.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Schuster JM, Grady MS. Medical management and adjuvant therapies in spinal metastatic disease. Neurosurg Focus. 2001;11(6):e3.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Brihaye J, Ectors P, Lemort M, Van Houtte P The management of spinal dural metastases. Adv Tech Stand Neurosurg. 1998;16:121-176.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Aiba H, Kimura T, Yamagami T, Watanabe N, Sakurai H, Kimura H et al. Prediction of skeletal-related events in patients with non-small cell lung cancer. Support Care Cancer. 2016;24(8):3361-3367. DOI: 10.1007/s00520-016-3167-5.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clinical Cancer Research. 2006;12(20 Pt 2):6243-6249.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Jang Khan NA, Ullah S, Siddiqui HU, Karim A. Spinal Cord Compression By Metastatic Thoracic Spine Paraganglioma. J Ayub Med Coll Abbottabad. 2016;28(3):617-619.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Aycan A, Celik S, Kuyumcu F, Akyol ME, Arslan M, Dogan E, Arslan H. Spinal Metastasis of Unknown Primary Accompanied by Neurologic Deficit or Vertebral Instability. World Neurosurg. 2018;109:e33-e42. DOI: 10.1016/j.wneu.2017.09.099.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Oka S, Matsumiya H, Shinohara S, Kuwata T, Takenaka M, Chikaishi Y et al. Total or partial vertebrectomy for lung cancer invading the spine. Ann Med Surg. (Lond.). 2016;15(12):1-4.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Hikata T, Isogai N, Shiono Y, Funao H, Okada E, Fujita N et al. A Retrospective Cohort Study Comparing the Safety and Efficacy of Minimally Invasive Versus Open Surgical Techniques in the Treatment of Spinal Metastases. 2017;30(8):1082-1087. DOI: 10.1097/BSD.0000000000000460.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Lei M, Li J, Liu Y, Jiang W, Liu S, Zhou S. Who are the Best Candidates for Decompressive Surgery and Spine Stabilization in Patients With Metastatic Spinal Cord Compression? A New Scoring System. Spine (Phila Pa 1976). 2016;41(18):1469-1476. DOI: 10.1097/BRS.0000000000001538.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Lagman C, Chung LK, Macyszyn L, Choy W, Smith ZA, Dahdaleh NS et al. Neurosurgery concepts: Key perspectives on imaging characteristics of spinal metastases, surgery for low back pain, anesthesia for disc surgery, and laminectomy versus laminectomy and fusion for lumbar spondylolisthesis. Surg Neurol Int. 2017;8:9. DOI: 10.4103/2152-7806.198736.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Nasser R, Nakhla J, Echt M, De la Garza Ramos R, Kinon MD, Sharan A, Yassari R. Minimally Invasive Separation Surgery with Intraoperative Stereotactic Guidance: A Feasibility Study. World Neurosurg. 2018;109:68-76. DOI: 10.1016/j. wneu.2017.09.067</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Тепляков ВВ, Шапошников АА, Сергеев ПС, Ахов АО, Ли ЯА, Лазукин АВ, Барышникова ДВ. Частота востребованности хирургического компонента в комплексном лечении метастатического поражения костей. Саркомы костей, мягких тканей и опухоли кожи. 2016;1:16-28.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Hernandez-Mier Y, Blondel WC, Daul C, Wolf D, Guillemin F. Fast construction of panoramic images for cystoscopic exploration. Comput Med Imaging Graph. 2010;34(7):579-592. DOI: 10.1016/j.compmedimag.2010.02.002.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Salvi J, Fernandez S, Pribanic T, Llado X. A state of the art in structured light patterns for surface profilometry. Patter Recognition. 2010;43(8);2666-2680.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Kumar N, Tan KA, Tan JH, Zaw AS, Hey HWD, Ruiz J, Stone E. The Influence of Histologic Subtype in Predicting Survival of Lung Cancer Patients With Spinal Metastases. Clin Spine Surg. 2018;31(1):E1-E7. DOI: 10.1097/ BSD.0000000000000475.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Bernard F, Lemje JM, Lucas O, Menei P. Postoperative quality-of-life assessment in patients with spine metastases treated with long-segment pedicle-screw fixation. J Neurosurg Spine. 2017;26(6):725-735. DOI: 10.3171/2016.9.SPINE16597.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Chang JH, Sangha A, Hyde D, Soliman H, Myrehaug S, Ruschin M et al. Positional Accuracy of Treating Multiple Versus Single Vertebral Metastases With Stereotactic Body Radiotherapy. Technol Cancer Res Treat. 2017;16(2):231-237. DOI: 10.1177/1533034616681674.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Giraldo A, Benavente S, Ramos M, Vergés R, Coronil O, Arbelaez L et al. Effectiveness of radiotherapy for metastatic spinal cord compression in patients with short life expectancy. Rep Pract Oncol Radiother. 2017;22(1):58-63. DOI: 10.1016/j.rpor.2016.09.007.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. Spine (Phila Pa 1976). 2005;30(19):2186-2191. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine. 2005;30(19):2186-2191.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Chaichana KL, Pendleton C, Wolinsky JP, Gokaslan ZL, Sciubba DM. Vertebral compression fractures in patients presenting with metastatic epidural spinal cord compression. Neurosurgery. 2009;65(2):267-274. DOI: 10.1227/01. NEU.0000349919.31636.05.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Yang SB, Cho W, Chang UK. Analysis of prognostic factors relating to postoperative survival in spinal metastases. J Korean Neurosurg Soc. 2012;51(3):127-134. DOI: 10.3340/ jkns.2012.51.3.127.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Aizenberg MR, Fox BD, Suki D, McCutcheon IE, Rao G, Rhines LD. Surgical management ofunknown primary tumors metastatic to the spine: clinical article. J Neurosurg Spine. 2012;16(1):86-92. DOI: 10.3171/2011.9.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Lau D, Leach MR, La Marca F, Park P. Independent predictors of survival and the impact of repeat surgery in patients undergoing surgical treatment of spinal metastasis. J Neurosurg Spine. 2012;17:565-576. DOI: 10.3171/2012.8.SPINE12449. Epub 2012 Sep 28.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Arrigo RT, Kalanithi P, Cheng I, Alamin T, Carragee EJ, Mindea SA et al. Predictors of survival after surgical treatment of spinal metastasis. Neurosurgery. 2011;68(3):674-681. DOI: 10.1227/NEU.0b013e318207780c.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Walcott BP, Cvetanovich GL, Barnard ZR, Nahed BV, Kahle KT, Curry WT Surgical treatment and outcomes of metastatic breast cancer to the spine. J Clin Neurosci. 2011;18(10):1336-1339. DOI: 10.1016/j.jocn.2011.02.020.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Zadnik PL, Goodwin CR, Karami KJ, Mehta AI, Amin AG, Groves ML et al. Outcomes following surgical intervention for impending and gross instability caused by multiple myeloma in the spinal column. J Neurosurg Spine. 2015;22(3):301-309. DOI: 10.3171/2014.9.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Sciubba DM, Gokaslan ZL, Suk I, Suki D, Maldaun MV, Mc-Cutcheon IE et al. Positive and negative prognostic variables for patients undergoing spine surgery for metastatic breast disease. Eur Spine J. 2007;16(10):1659-1667.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Ogihara S, Seichi A, Hozumi T, Oka H, Ieki R, Nakamura K, Kondoh T. Prognostic factors for patients with spinal metastases from lung cancer. Spine (Phila Pa 1976). 2006;31(14): 1585-1590.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Wibmer C, Leithner A, Hofmann G, Clar H, Kapitan M, Berghold A, Windhager R. Survival analysis of 254 patients after manifestation of spinal metastases: evaluation of seven preoperative scoring systems. Spine (Phila Pa 1976). 2011;36(23):1977-1986. DOI: 10.1097/BRS.0b013e3182011f84.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Dobran M, Iacoangeli M, Brunozzi D, Nasi D, Di Somma L, Moriconi E et al. Surgical treatments of spinal metastases: analysis of prognostic factors during a seven-year experience. J Neurosurg Sci. 2018;62(1):94-97. DOI: 10.23736/S0390-5616.16.03587-6.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Yamashita T, Siemionow KB, Mroz TE, Podichetty V, Lieberman IH. A prospective analysis of prognostic factors in patients with spinal metastases: use of the revised. Tokuhashi score. 2011;36(11):910-917. DOI: 10.1097/BRS.0b013e3181e56ec1.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>De la Garza Ramos R, Goodwin CR, Jain A, Abu-Bonsrah N, Fisher CG, Bettegowda C, Sciubba DM. Development of a Metastatic Spinal Tumor Frailty Index (MSTFI) Using a Nationwide Database and Its Association with Inpatient Morbidity, Mortality, and Length of Stay After Spine Surgery. World Neurosurg. 2016;95:548-555.e4. DOI: 10.1016/j. wneu.2016.08.029.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Frankel HL, Hancock DO, Hyslop G, Melzak J, Michaelis LS, Ungar GH et al. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. Paraplegia. 1969;7:179-192.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Peus D, Newcomb N, Hofer S. Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation. BMC Med Inform Decis Mak. 2013;19;13:72. DOI: 10.1186/1472-6947-13-72.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Daniel JW, Veiga JC. Prognostic Parameters and Spinal Me-tastases: A Research Study Prognostic Parameters and Spinal Metastases. PLoS One. 2014;13;9(10):e109579. DOI: 10.1371/ journal.pone.0109579.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Rades D, Douglas S, Veninga T et al. Prognostic factors in a series of504 breast cancer patients with metastatic spinal cord compression. Strahlenther Onkol. 2012;188(4):340-5. DOI: 10.1007/s00066-011-0061-4.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Eleraky M, Papanastassiou I, Vrionis FD. Management of metastatic spine disease. Curr Opin Support Palliat Care. 2010;4(3):182-188. DOI: 10.1097/SPC.0b013e32833d2fdd.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Dean M, Harris JD, Regnard C, Hockley J. Emergencies. Symptom Relief in Palliative Care. Oxford, United Kingdom: Radcliffe Publishing. 2011:201-219.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Waller A, Caroline NL. Spinal Cord Compression. Handbook of Palliative Care in Cancer. 5nd ed. Boston, MA. 2013:301-308.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Kataoka M, Kunisada T, Tanaka M et al. Statistical analysis of prognostic factors for survival in patients with spinal metastasis. Acta Med Okayama. 2012;66(3):213-219.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Leithner A, Radl R, Gruber G. et al. Predictive value of seven preoperative prognostic scoring systems for spinal metastases. Eur Spine J. 2008;17(11):1488-1495. DOI: 10.1007/s00586-008-0763-1.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>La Combe B, Gaillard S, Bennis S, Chouaid C. Management of spinal metastases of lung cancer. Rev Mal Respir. 2013;30(6):480-489. DOI: 10.1016/j.rmr.2012.12.016.</mixed-citation></ref></ref-list></back></article>
